Cyclerion Therapeutics (CYCN) Net Shares Issued and Repurchased (2019 - 2025)

Cyclerion Therapeutics has reported Net Shares Issued and Repurchased for 7 years, with the latest figure at $5990.0 in Q1 2025.

• On a quarterly basis, Net Shares Issued and Repurchased changed N/A year-over-year to $5990.0 in Q1 2025; TTM through Mar 2025 was $5990.0, a N/A change from a year earlier, with the FY2024 full-year figure at $55849.0, changed N/A from the prior year.
• Net Shares Issued and Repurchased was $5990.0 for Q1 2025 at Cyclerion Therapeutics, down from $55849.0 in the prior quarter.
• The five-year high for Net Shares Issued and Repurchased was $1.4 million in Q1 2022, with the low at $4000.0 in Q2 2023.
• Average Net Shares Issued and Repurchased over 5 years is $258255.6, with a median of $55849.0 recorded in 2024.
• The sharpest annual moves came in 2021 and 2022: Net Shares Issued and Repurchased declined 9.55% in 2021, then soared 858.63% in 2022.
• Over 5 years, Net Shares Issued and Repurchased stood at $150000.0 in 2021, then jumped by 858.63% to $1.4 million in 2022, then sank by 99.72% to $4000.0 in 2023, then jumped by 1296.22% to $55849.0 in 2024, then tumbled by 89.27% to $5990.0 in 2025.
• The last three Net Shares Issued and Repurchased figures came in at $5990.0 (Q1 2025), $55849.0 (Q4 2024), and $4000.0 (Q3 2023), per Business Quant data.